DK1071442T3 - Fremgangsmåder og præparater til peptidsyntese (T-20) - Google Patents

Fremgangsmåder og præparater til peptidsyntese (T-20)

Info

Publication number
DK1071442T3
DK1071442T3 DK99912802T DK99912802T DK1071442T3 DK 1071442 T3 DK1071442 T3 DK 1071442T3 DK 99912802 T DK99912802 T DK 99912802T DK 99912802 T DK99912802 T DK 99912802T DK 1071442 T3 DK1071442 T3 DK 1071442T3
Authority
DK
Denmark
Prior art keywords
peptides
methods
present
peptide
synthesis
Prior art date
Application number
DK99912802T
Other languages
Danish (da)
English (en)
Inventor
Brian Bray
Myung-Chol Kang
Maynard Lichty
Catherine Mader
Gene Merutka
Original Assignee
Trimeris Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/045,920 external-priority patent/US6281331B1/en
Application filed by Trimeris Inc filed Critical Trimeris Inc
Application granted granted Critical
Publication of DK1071442T3 publication Critical patent/DK1071442T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK99912802T 1998-03-23 1999-03-22 Fremgangsmåder og præparater til peptidsyntese (T-20) DK1071442T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/045,920 US6281331B1 (en) 1998-03-23 1998-03-23 Methods and compositions for peptide synthesis
US09/071,877 US6015881A (en) 1998-03-23 1998-05-01 Methods and compositions for peptide synthesis
PCT/US1999/006230 WO1999048513A1 (fr) 1998-03-23 1999-03-22 Methodes et compositions de synthese de peptides

Publications (1)

Publication Number Publication Date
DK1071442T3 true DK1071442T3 (da) 2005-10-24

Family

ID=26723345

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99912802T DK1071442T3 (da) 1998-03-23 1999-03-22 Fremgangsmåder og præparater til peptidsyntese (T-20)

Country Status (13)

Country Link
EP (1) EP1071442B9 (fr)
JP (1) JP4602547B2 (fr)
CN (1) CN100383158C (fr)
AT (1) ATE299029T1 (fr)
AU (1) AU751358B2 (fr)
BR (1) BR9909018A (fr)
CA (1) CA2324348C (fr)
DE (1) DE69926061T2 (fr)
DK (1) DK1071442T3 (fr)
ES (1) ES2245505T3 (fr)
NZ (1) NZ507083A (fr)
TW (1) TWI233931B (fr)
WO (1) WO1999048513A1 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6281331B1 (en) * 1998-03-23 2001-08-28 Trimeris, Inc. Methods and compositions for peptide synthesis
US6469136B1 (en) * 1999-07-07 2002-10-22 Trimeris, Inc. Methods and composition for peptide synthesis
KR100614714B1 (ko) 2001-06-15 2006-08-21 에프. 호프만-라 로슈 아게 ｇｐ41 단편의 아세틸화
PL375254A1 (en) * 2002-07-24 2005-11-28 F.Hoffmann-La Roche Ag Pegylated t20 polypeptide
ATE376556T1 (de) 2003-12-31 2007-11-15 Hoffmann La Roche Verfahren zur peptidsynthese unter verwendung einer reduzierten menge an entschützungsmittel
WO2005063799A2 (fr) * 2003-12-31 2005-07-14 F.Hoffmann-La Roche Ag Synthese de peptides et deprotection a l'aide d'un co-solvant
ES2315729T3 (es) 2003-12-31 2009-04-01 F. Hoffmann-La Roche Ag Procedimiento y sistemas para la recuperacion de peptidos.
DE602005017188D1 (de) * 2004-12-30 2009-11-26 Hoffmann La Roche Synthese des peptides t-20 aus peptidfragmenten als zwischenprodukte
EP2013223A2 (fr) 2006-05-03 2009-01-14 Mallinckrodt Inc. Composition et procédé de séparation de peptides protégés d'avec une résine
WO2009014177A1 (fr) * 2007-07-25 2009-01-29 Ajinomoto Co., Inc. Procédé d'élimination sélective d'un dérivé dibenzofulvène
WO2009053315A1 (fr) * 2007-10-27 2009-04-30 F. Hoffmann-La Roche Ag Synthèse de peptides insulinotropes à l'aide de techniques hybrides utilisant une phase solide et une phase en solution
WO2009074483A2 (fr) * 2007-12-11 2009-06-18 F. Hoffmann-La Roche Ag Synthèse de peptides insulinotropiques mettant en œuvre des techniques de combinaison de phases solides et en solution
WO2010016551A1 (fr) 2008-08-06 2010-02-11 味の素株式会社 Procédés d'élimination du dibenzofulvène
CA2736113A1 (fr) * 2008-09-03 2010-03-11 Scinopharm Taiwan, Ltd. Procede pour la preparation de pramlintide
US20110288235A1 (en) * 2008-09-03 2011-11-24 Scinopharm Taiwan Ltd. Process for the Preparation of Pramlintide
WO2011095989A2 (fr) * 2010-02-04 2011-08-11 Matrix Laboratories Ltd Procédé amélioré pour préparer de l'enfuvirtide
PL219569B1 (pl) * 2010-02-19 2015-05-29 Peptaderm Spółka Z Ograniczoną Odpowiedzialnością Cykliczne tetrapeptydy i ich zastosowanie
CN103374054B (zh) * 2012-04-28 2014-12-24 上海第一生化药业有限公司 一步法固相合成多肽的方法
GB201315335D0 (en) 2013-08-29 2013-10-09 Of Singapore Amino diacids containing peptide modifiers
JP7415022B2 (ja) * 2020-02-05 2024-01-16 イーライ リリー アンド カンパニー 三連樹脂反応器ペプチド合成機
CN114315957B (zh) * 2021-12-30 2023-07-07 深圳瑞德林生物技术有限公司 一种多肽的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01501547A (ja) * 1986-06-12 1989-06-01 バイオジェン　ナームローズ　ベンノットシャップ Ｈｉｖ感染の病因に関するペプチド
US4787222A (en) * 1986-11-24 1988-11-29 Novatek Medical Inc. Combination lock for blood identification system
US5444044A (en) * 1992-03-26 1995-08-22 New York Blood Center Synthetic polypeptides as inhibitors of HIV-1
US6479055B1 (en) * 1993-06-07 2002-11-12 Trimeris, Inc. Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission
US5464933A (en) * 1993-06-07 1995-11-07 Duke University Synthetic peptide inhibitors of HIV transmission
EP0708659A4 (fr) * 1993-06-07 2000-08-23 Genentech Inc Polypeptides d'enveloppe du vih
UA43350C2 (uk) * 1993-09-11 2001-12-17 Полімун Саіентіфік Іммунобіологіше Форшунг Гмбх Пептид, який викликає утворення антитіл, що проявляють нейтралізуючу активність відносно штамів та/або ізолятів віл-1 , та/або пригнічують злиття уражених віл-1 клітин, фармацевтичний засіб для утворення антитіл, спосіб отримання пептиду для утворення антитіл, спосіб отримання антитіл, антитіло iga, що проявляє віл-1 нейтралізуючу активність та/або пригнічує злиття уражених віл-1 клітин
AU722895B2 (en) * 1996-02-09 2000-08-10 F. Hoffmann-La Roche Ag Synthesis of VIP analog

Also Published As

Publication number Publication date
CA2324348A1 (fr) 1999-09-30
CN1303299A (zh) 2001-07-11
CN100383158C (zh) 2008-04-23
JP2002507576A (ja) 2002-03-12
ATE299029T1 (de) 2005-07-15
DE69926061T2 (de) 2006-06-01
AU751358B2 (en) 2002-08-15
JP4602547B2 (ja) 2010-12-22
EP1071442B1 (fr) 2005-07-06
AU3109799A (en) 1999-10-18
ES2245505T3 (es) 2006-01-01
WO1999048513A1 (fr) 1999-09-30
NZ507083A (en) 2003-10-31
DE69926061D1 (de) 2005-08-11
EP1071442A4 (fr) 2002-06-05
EP1071442A1 (fr) 2001-01-31
CA2324348C (fr) 2006-03-14
EP1071442B9 (fr) 2006-01-18
BR9909018A (pt) 2001-10-16
TWI233931B (en) 2005-06-11

Similar Documents

Publication Publication Date Title
DK1071442T3 (da) Fremgangsmåder og præparater til peptidsyntese (T-20)
WO2001034635A3 (fr) Methodes et compositions pour la synthese de peptides
BRPI9909018B8 (pt) processo para a síntese de um peptídeo
RU94045919A (ru) Антитела, клетки, полипептид, днк векторы, способ получения полипептида, способ получения антитела, фармацевтическая композиция
DK1129190T3 (da) Human TSLP DNA og polypeptider
DE69732640D1 (de) Festphasen-peptidsynthese
KR960705850A (ko) 사람 쿠니즈형 프로테아제 저해인자(human kunitz-type protease inhibitors)
AUPR107800A0 (en) Peptide and nucleic acid molecule ii
MX348154B (es) Anticuerpos de enlace a il-1-beta y fragmentos de los mismos.
MXPA04008077A (es) Anticuerpos ant-a° y su uso.
BG102983A (en) Extramembrane protein 106 polypeptide of moraxella catarrhalis, its gene sequence and application
AR036196A1 (es) Agentes de contraste multimericos dirigidos a base de peptidos
UA40621C2 (uk) Моноклональне антитіло, гібридомна клітинна лінія, поліпептид (варіанти), фрагмент днк (варіанти), фармацевтична композиція, спосіб одержання моноклонального антитіла
DK1185648T3 (da) Fremgangsmåder og sammensætninger til inhibition af neoplastisk cellevækst
EP0815125A4 (fr) RECEPTEUR gC1q, ZONE DE LIAISON DE gp120 DE VIH-1 A CE DERNIER, ET PEPTIDES ET ANTICORPS DE CIBLAGE ASSOCIES
DK0479948T3 (da) Sammensætninger og fremgangsmåder til syntese af natriuretisk protein-receptor B og anvendelsesfremgangsmåder
DK1484338T3 (da) Fremgangsmåder og sammensætninger til inhibition af neoplastisk cellevækst
AR006188A1 (es) "composicion farmaceutica para inhibir la actividad de serinproteasa, metodo in vitro para inhibir la actividad de serinproteasa y metodo para preparar dicha composicion".
CA2170515A1 (fr) Sequences de nucleotide pour de nouvelles proteines de type tyrosine-phosphatase
Paolini et al. Amino acid sequence, post-translational modifications, binding and labelling of porcine odorant-binding protein
ATE394482T1 (de) Verfahren und zusammensetzungen für peptid-, protein- und peptidomimetische synthese
BR0312889A (pt) Polipeptìdeo t20 peguilado
DE60118359D1 (de) Humanische pellino-polypeptide
NO984491L (no) SCF-analogpreparater og fremgangsmÕte for fremstilling av disse
EP0587541B1 (fr) Procédé de purification de protéine Big-endothéline